The Series A round was led by MMC Ventures with participation from Episode 1, Seedcamp, and angel investors.
Sano Genetics
Sano Genetics develops software that connects patients with genetic and personalised medicine researchers.
Sano Genetics builds patient-friendly software that connects individuals with rare and chronic conditions directly to personalised medicine research. The platform helps biotechnology and pharmaceutical firms accelerate clinical trials and improve participant engagement.
Founders

Patrick Short
CEO and co-founder
Patrick brings genomic and machine learning experience, currently serving as co-founder and CEO of Sano Genetics after completing a PhD in mathematical genomics and medicine.
LinkedInCharlotte Guzzo
COO

William Jones
CTO
William co-founded Sano Genetics, where he served as chief technology officer for seven years. He previously held roles at Faculty and The Genome Analysis Centre.
LinkedInInvestors
- £8.3M
- £2.5M
- £500K
Funding history
The seed round was led by Episode1 with backing from Seedcamp, Cambridge Enterprise, and January Ventures to fund DNA testing kits and platform development.
The seed round was supported by Seedcamp alongside Cambridge Enterprise, angel investors, and grant providers.

